A Non-interventional Trial With Avastin as Front-line Treatment for Ovarian Cancer
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 16 Jun 2017
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin; Paclitaxel
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- Acronyms BOVARI
- Sponsors Roche
- 12 Jun 2017 Planned End Date changed from 1 Jun 2017 to 30 Sep 2017.
- 12 Jun 2017 Planned primary completion date changed from 1 Jun 2017 to 30 Sep 2017.
- 01 Aug 2016 Status changed from recruiting to active, no longer recruiting.